CytoDyn Inc.
CYDY- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001175680
No open-market purchases or sales by CytoDyn Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $35.2K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by CytoDyn Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for CytoDyn Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Simes Stephen M | Director | – | Mar 24, 2026 | 1 |
| Hoffman Robert | Chief Financial Officer | – | Mar 24, 2026 | 1 |
| Dunlap Ryan | Director | – | Mar 24, 2026 | 1 |
| Urbach Tanya Durkee | Director | – | Mar 24, 2026 | 1 |
| Ndhlovu Lishomwa C | Director | – | Mar 24, 2026 | 1 |
| Brunke Karen J | Director | – | Mar 24, 2026 | 1 |
| Blok Tyler | Chief Legal Officer | – | Mar 24, 2026 | 1 |
| Lalezari Jacob P | Chief Executive Officer | – | Mar 24, 2026 | 1 |
| Migliarese Antonio | CFO | 183,207 | Jan 5, 2024 | 0 |
| Arman Arvin Cyrus | President | 1,081,334 | Feb 14, 2023 | 0 |
| Kelly Scott A. | CMO | 2,184,037 | Nov 30, 2022 | 0 |
| Ray Nitya G. | Chief Technology Officer | 500,090 | Nov 17, 2022 | 0 |
| Recknor Chris P | See Remarks | 716,746 | Jun 8, 2022 | 0 |
| Timmins Alan P | Director | – | Nov 30, 2021 | 0 |
| Patel Samir Rashmikant | Director | – | Nov 30, 2021 | 0 |
| Gardiner Gordon A | Director | – | Nov 30, 2021 | 0 |
| Naydenov Jordan G | Director | 7,990,211 | Oct 20, 2021 | 0 |
| Pourhassan Nader | President & CEO | 1,850,688 | Oct 20, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.